These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Round table discussion of Rifampicin. Turin, 18 December 1968]. De Mattia R Minerva Med; 1969 Dec; 60(96):4781-2. PubMed ID: 5357542 [No Abstract] [Full Text] [Related]
4. Recent investigations on the biological properties of rifampicin. Furesz S Acta Tuberc Pneumol Belg; 1969; 60(3):266-9. PubMed ID: 5371663 [No Abstract] [Full Text] [Related]
5. [Rifampicin. Interactions with other drugs]. Salvá JA; Erill S Arch Farmacol Toxicol; 1975 Mar; 1(1):82-90. PubMed ID: 1231650 [No Abstract] [Full Text] [Related]
6. [General remarks on Rifampicin]. Toscano F Minerva Med; 1969 Dec; 60(96):4783-9. PubMed ID: 5357543 [No Abstract] [Full Text] [Related]
7. Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Li J; Zhu M; Rajamani S; Uversky VN; Fink AL Chem Biol; 2004 Nov; 11(11):1513-21. PubMed ID: 15556002 [TBL] [Abstract][Full Text] [Related]
8. [Detection of rpoB mutations in rifampicin-resistant Mycobacterium kansasii]. Yoshida S; Suzuki K; Tsuyuguchi K; Iwamoto T; Tomita M; Okada M; Sakatani M Kekkaku; 2006 Jul; 81(7):475-9. PubMed ID: 16910599 [TBL] [Abstract][Full Text] [Related]
9. [Rifampicin, a new antitubercular bactericide]. Thibault P Presse Med (1893); 1970 Feb; 78(11):501-2. PubMed ID: 5418624 [No Abstract] [Full Text] [Related]
10. Effect of rifampicin and tetracycline alone and in combination against Brucella suis. De Rycke J Ann Microbiol (Paris); 1980; 131B(3):277-87. PubMed ID: 7469256 [TBL] [Abstract][Full Text] [Related]
11. Therapy of experimental staphylococcal mastitis in the mouse with cloxacillin and rifampicin, alone and in combination. Craven N; Anderson JC Res Vet Sci; 1981 Nov; 31(3):295-300. PubMed ID: 6919178 [TBL] [Abstract][Full Text] [Related]
13. [Lymphogenic introduction into lesser circulation of orally administered rifampicin in standard and liposomal forms]. Petrenko TI; Ursov IG; Kurunov IuN; Borodin IuI; Sidorova LD Probl Tuberk; 1995; (3):53-4. PubMed ID: 7617640 [TBL] [Abstract][Full Text] [Related]
14. [Experimental pharmacodynamic study of rifampicin administered by various methods]. Shapovalov VP; Mil'chenko KP; Kovalenko NN Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830 [TBL] [Abstract][Full Text] [Related]
15. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man. Furesz S; Scotti R; Pallanza R; Mapelli E Arzneimittelforschung; 1967 May; 17(5):534-7. PubMed ID: 5631581 [No Abstract] [Full Text] [Related]
16. Rifampicin desacetylation in the human organism. Maggi N; Furesz S; Pallanza R; Pelizza G Arzneimittelforschung; 1969 Apr; 19(4):651-4. PubMed ID: 5819167 [No Abstract] [Full Text] [Related]
17. [Effects of rifampicin and streptomycin on the concentrations of testosterone and cortisol in the blood of men (author's transl)]. Nocke-Finck L; Breuer H; Reimers D J Clin Chem Clin Biochem; 1980 Dec; 18(12):897-9. PubMed ID: 7205148 [TBL] [Abstract][Full Text] [Related]
18. [Increased desacetylation of rifampicin and an adverse reaction (author's transl)]. Nakagawa H; Umene Z; Sunahara S Kekkaku; 1981 Dec; 56(12):577-86. PubMed ID: 7328994 [No Abstract] [Full Text] [Related]
19. Effect of rifampicin on theophylline pharmacokinetics in human beings. Rao S; Singh SK; Narang RK; Rajagopalan PT J Assoc Physicians India; 1994 Nov; 42(11):881-2. PubMed ID: 7868490 [TBL] [Abstract][Full Text] [Related]
20. Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death. Meng F; Marek P; Potter KJ; Verchere CB; Raleigh DP Biochemistry; 2008 Jun; 47(22):6016-24. PubMed ID: 18457428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]